Silence Therapeutics Plc (SLNCF)
6.52
+0.15
(+2.35%)
USD |
OTCM |
Oct 30, 16:00
Silence Therapeutics 30-Day Average Daily Volume : 8735.00 for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 8735.00 |
| October 29, 2026 | 343.57 |
| October 28, 2026 | 343.57 |
| October 27, 2026 | 343.57 |
| October 26, 2026 | 343.57 |
| October 23, 2026 | 343.57 |
| October 22, 2026 | 343.57 |
| October 21, 2026 | 343.50 |
| October 20, 2026 | 343.50 |
| October 19, 2026 | 276.67 |
| October 16, 2026 | 90.00 |
| October 15, 2026 | 90.00 |
| October 14, 2026 | 90.00 |
| October 13, 2026 | 90.00 |
| October 12, 2026 | 90.00 |
| October 09, 2026 | 90.00 |
| October 08, 2026 | 85.33 |
| October 07, 2026 | 85.33 |
| October 06, 2026 | 86.67 |
| October 05, 2026 | 75.00 |
| October 02, 2026 | 75.00 |
| October 01, 2026 | 75.00 |
| September 30, 2026 | 73.33 |
| September 29, 2026 | 91.67 |
| September 28, 2026 | 98.80 |
| Date | Value |
|---|---|
| September 25, 2026 | 98.80 |
| September 24, 2026 | 98.80 |
| September 23, 2026 | 132.83 |
| September 22, 2026 | 141.17 |
| September 21, 2026 | 164.50 |
| September 18, 2026 | 164.50 |
| September 17, 2026 | 164.50 |
| September 16, 2026 | 164.50 |
| September 15, 2026 | 164.50 |
| September 14, 2026 | 164.57 |
| September 11, 2026 | 164.57 |
| September 10, 2026 | 164.57 |
| September 09, 2026 | 164.57 |
| September 08, 2026 | 164.57 |
| September 04, 2026 | 164.57 |
| September 03, 2026 | 164.57 |
| September 02, 2026 | 164.57 |
| September 01, 2026 | 164.57 |
| August 31, 2026 | 164.57 |
| August 28, 2026 | 164.57 |
| August 27, 2026 | 164.57 |
| August 26, 2026 | 162.57 |
| August 25, 2026 | 162.57 |
| August 24, 2026 | 161.23 |
| August 21, 2026 | 94.57 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Biodexa Pharmaceuticals Plc | 364792.6 |
| NuCana Plc | 179298.1 |
| Mereo BioPharma Group Plc | 1.234M |
| Compass Pathways Plc | 2.518M |
| HemoGenyx Pharmaceuticals Plc | 0.00 |